Publicaciones en las que colabora con Alfonso Muriel García (51)

2024

  1. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

  2. High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients with Acute Pulmonary Embolism

    JAMA Cardiology, Vol. 9, Núm. 1, pp. 64-70

  3. Impact of a pulmonary embolism response team (PERT) in the prognosis of patients with acute symptomatic pulmonary embolism

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 141-149

  4. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

  5. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  6. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

  7. Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism

    Thrombosis Research, Vol. 233, pp. 18-24

2023

  1. Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020

    JACC: CardioOncology, Vol. 5, Núm. 6, pp. 758-772

  2. Comparison of various prognostic scores for identification of patients with intermediate-high risk pulmonary embolism

    Thrombosis Research, Vol. 223, pp. 61-68

  3. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study

    Thrombosis Research, Vol. 228, pp. 1-9

  4. Identification of Low-risk Patients With Acute Symptomatic Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 575-580

  5. National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism

    Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 7, pp. 716-724

  6. Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study

    Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 7, pp. 725-735

2022

  1. Comparison of Full-Dose vs Moderate-Dose Systemic Thrombolysis for the Treatment of Patients With Acute Pulmonary Embolism

    Chest, Vol. 162, Núm. 2, pp. 448-451

  2. Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study

    Thrombosis and Haemostasis, Vol. 123, Núm. 6, pp. 649-662

  3. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Chest, Vol. 161, Núm. 2, pp. 524-534

  4. Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. 412-417

  5. Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism

    The European respiratory journal, Vol. 59, Núm. 2

  6. Rate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19-Associated Venous Thromboembolism

    JAMA internal medicine, Vol. 182, Núm. 12, pp. 1326-1328

  7. Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study

    Thrombosis Research, Vol. 214, pp. 122-131